Volume : 08, Issue : 12, December – 2021
Title:
42.PULSATILE DRUG DELIVERY SYSTEM- A REVIEW
Authors :
Tahura Mahmood*, Shifa Rousheen
Abstract :
Pulsatile-release delivery systems are gaining popularity for the development of medications for which conventional controlled-release systems with a continuous release are ineffective. Pulsatile Drug Delivery Systems are gaining popularity because they deliver the drug to the appropriate place, at the right time, and in the right amount, ensuring spatial and temporal delivery while also boosting patient compliance. Humans have endogenous circadian rhythms that are controlled by the body’s master circadian clock. The drug release profile of the product is sigmoidal, with a period of no release (lag time) followed by quick and total drug release. are not consistent, but change through time. Despite the fact that much drug delivery research has focused on constant drug release rates due to the limitations of delivering drugs according to disease rhythmicity, clinical studies show that the magnitude of rhythmic differences can be a significant predictor of when the most morbid and mortal events will occur during a 24-hour period.
The range of systems and approaches that can be used to deliver therapeutics is growing and advancing at an incredible rate, so learning about the advances in drug delivery has important implications for anyone working in health care and related sectors. Currently, Pulsatile drug delivery is gaining cumulative attention as it offers a more sophisticated approach to the traditional sustained drug delivery, a constant amount of drug released per unit time or constant blood levels. Pulsatile drug delivery aims to release drugs on a programmed pattern i.e.: at appropriate time and/or at appropriate site of action.
Cite This Article:
Please cite this article in press Tahura Mahmood et al, Pulsatile Drug Delivery System- A Review ., Indo Am. J. P. Sci, 2021; 08(12).
Number of Downloads : 10
References:
1. Ansels pharmaceutical dosage forms and drug delivery systems loyd V. allen, Jr, Nicholas G Popovich, howard C. ansel
2. Arora S, Ali J, Ahuja A, Baboota S, Qureshi J. Pulsatile drug delivery systems: An Approach for controlled drug delivery. Indian J Pharm Sci. 2006; 68:295–300. doi: 10.4103/0250-474X.26655. [CrossRef] [Google Scholar]
3. Balaban SM, Pike JB, Smith JP, Baile CA. Osmotically driven delivery devices with pulsatile effect. US Patent 5,209,746; 1993
4. Belgamwar VS, Gaikwad MV, Patil GB, Surana S. Pulsatile drug delivery systems. Asian J Pharm 2008; 141-5. [Google Scholar]
5. Bessemer T, Otto I, Bodmeier R. Pulsatile drug-delivery systems. Crit Rev Ther Drug Carrier Syst.
6. Burns JS, Stevens HNE, McEwen J, Pritchard G, Brewer FM, Clarke A, et al. Pulsatile drug delivery system. J Control Release. 1996; 38:151
7. Formulation parameters affecting the performanceT. Bussemer, I. Otto, R. Bodmeier, Pulsatile drug-delivery systems, Crit. Rev. Ther. Drug Carrier Syst. 18(5): 433-458
8. from: http://www.emea.europa.eu
9. Fukui E, Miyamura N, Uemura K, Kobayashi M. Preparation of enteric coated timedrelease press-coated tablets and evaluation of their function by in vitro and in vivo tests for colon targeting. Int J Pharm 2000; 204:7-15
10. fumarate. Trop J Pharma Res 2014; 13:489-49. 4.Patwekar SL, Baramade MK. Controlled release approach to novel multi-particulate drug delivery system. Int J Pharm Pharma Sci 2012; 4:756-63.
11. G. Dharmamoorthy and L. Nandhakumar. Chronotherapeutic: a range of newer drug delivery approaches for better patient compliance. Int. J. Applied Bio. Pharm. Tech. 2011; 2(4):110-20. 7. Richard J. Martin. Nocturnal asthma: circadian rhythms and therapeutic interventions. American Review of Respiratory Disease. Supplement: Airway Diseases Update. 1993; 147: S25-S28.
12. G.Dharmamoorthy and L.nandhakumar. chronotherapeutic: a range of newer drug delivery approaches for better.
13. Ghimire M, McInnes F, Watson D, Mullen A, Stevens N. (2007). In-vitro/in-vivo correlation of pulsatile drug release from
14. Government of India, Ministry of health and welfare. (1996). Indian Pharmacopoeia, Controller of Publications, Delhi, 80-81.
15. http://www.uspharmacist.com/oldformat.asp?url=newlook/files/Feat/ACF2F15.cfm&pub_i
16. International Conferences on Harmonization. (2003). Stability Testing of new Drug Substances and Products. Available
17. Jose S, Dhanya K, Cinu TA, Litty J, Chacko AJ. Colon targeted drug delivery: different approaches. J Young Pharmacist 2009; 1:13-9.
18. Joseph R Robinson. (2000). Controlled drug delivery, fundamentals and application, 2nd edition, 6, 373-379.
19. Kikuchi A, Okano T. Pulsatile drug release control using hydrogels. [PubMed] [CrossRef] [Google Scholar]
20. Lalwani A, Santani DD. Pulsatile drug delivery systems. Indian J Pharm Sci. 2007; 69:489–97. doi: 10.4103/0250-474X.36932. [CrossRef] [Google Scholar]
21. MacNeil ME, Rashid A, Stevens HN. Dispensing device. World Patent 1990; 9009168.
22. Maroni A, Zema L, Cerea M, Sangalli ME. Oral Pulstile drug delivery systems. Expert Opin Drug Delivery 2005; 2: 855-71. Conte, U., Arsizio, B., Manna, A.L., Comolobo, P.: US486584 (1989)
23. Medlicott NJ, Tucker IG. Pulsatile release from subcutaneous implants. Adv Drug Dev Rev 1999; 38: 139-49
24. Modasiya Moin K. And Patel Vishnu M.: Pulsatile Drug Delivery System for Colon – A Review. International Journal of Research in Pharmaceutical and Biomedical Sciences 2011; 2(3): 934-941.
25. Moturi Vihar, Khan Arshad Bashir: Chronotherapeutic in Development of Pulsatile Delivery Systems. International Journal of Pharmaceutical Sciences and Research 2012; 3(11):4086-4095.
26. Nitin DG, Kadam VJ, Jadhav KR, Kyatanwar AU, Patel UJ. Pulsatile drug delivery system. Journal Pharm Res. 2010; 3:120–1. [Google Scholar]
27. Patel GC, Patel MM. Developing a modified PulsincapTM system. Pharm Tech Europe 2009; 21.48. Steve E. Bio-enhancement technologies improve absorption of insoluble drugs in oral dosage forms. Drug Delivery Syst 2007;2:
28. Patel Vipul P, Soniwala Moinuddin M: Pulsatile Drug Delivery System for Treatment of Various Inflammatory Disorders-A Review. International Journal of Drug Development & Research 2012; 4(3):67-87.
29. Prasanth V.V, Modi Mitesh P., and Mathew Sam T: Pulsatile: A tool for circadian rhythm – a review. Journal of Drug Delivery & Therapeutics 2012; 2(1): 58-65 Bussemer, T., Bodmeier, R., (2003).
30. press-coated tablet formulations: A pharmacoscintigraphic study in the beagle dogs. Eur. J. Pharm. BioPharma, 2007, 67(2) 515-523.
31. Recent advances in oral pulsatile drug delivery Lida E Kalantzi 1, Evangelos Karavas, Efthimios X Koutris, Dimitrios N Bikiaris.
32. Reddy Ravi Kumar J. C. Madhu Sadhana Chetty: Review on: Pulsatile Drug Delivery Systems. Journal 0f Pharmaceutical Sciences & Research 2009; 1(4): 109-115.
33. Ross AC, MacRae RJ, Walther M, Stevens HN. Chronopharmaceutical drug delivery from a pulsatile capsule device based on programmable erosion. J Pharm Pharmacol. 2000; 52:903–9. doi: 10.1211/0022357001774787. [PubMed] [CrossRef] [Google Scholar]
34. S.K. Gupta, G. Sathyan, Pharmacokinetics of an oral once- day controlled-release oxybutynin formulation compared with immediate release oxybutynin, J. Clin. Pharmacol. 39(3): 289-296 (1999)
35. Skye Pharma. 2010. Skye Pharma – Drug Delivery Specialists. Available from: www.skypharma.com
36. T. Bussemer, I. Otto, R. Bodmeier, Pulsatile drug-delivery systems, Crit. Rev. Ther. Drug Carr. Syst. 18 (5) (2001)433– 458.
37. Troy MH. Timing drug availability with therapeutic need. Specialty Pharma 2006;2:
38. ultrasound for controlled delivery of therapeutics. Kost J Clin Mater. 1993; 13(1-4):155-61
39. Vyas SP and Khar RK. (2002). Controlled drug Delivery – Fundamentals and application, Vallabh Prakashan – New Delhi, First Edition.
40. W.A. Ritschel, H. Forusz, Chrono pharmacology: a review of drugs studies, Meth. Find. Exp. Clin. Pharmocol. 16 (1)(1994) 57– 75.
41. Why degradable polymers undergo surface erosion or bulk erosion Friederike von Burkersrodaa LuiseSchedlb Achim Göpfericha